Edgewise Therapeutics, Inc. - Common Stock (NQ:EWTX)

29.07 +0.39 (+1.34%)

Streaming Delayed Price Updated: 2:36 PM EST, Jan 29, 2026 Add to My Watchlist

Price and Volume

Volume	233,112
Open	28.67
Bid (Size)	29.04 (100)
Ask (Size)	29.09 (200)
Prev. Close	28.68
Today's Range	28.39 - 29.32
52wk Range	10.60 - 30.48
Shares Outstanding	105,341,296
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗

December 29, 2025

A full exit during a volatile stretch raises a sharper question than timing alone.

Via The Motley Fool

Why Edgewise Therapeutics Stock Rocked the Market Today ↗

December 24, 2025

The company just might have a winner on its hands with a pipeline heart disease treatment.

Via The Motley Fool

Performance

YTD	+22.4%	+22.4%
1 Month	+18.1%	+18.1%
3 Month	+78.0%	+78.0%
6 Month	+104.3%	+104.3%
1 Year	+4.6%	+4.6%

More News

Let's take a look at the stocks that are in motion in today's session. ↗

December 24, 2025

Via Chartmill

Edgewise Therapeutics Stock Jumps After Trial Update For Genetic Heart Disease — Wall Street Eyes A Potential Standout ↗

December 24, 2025

Via Stocktwits

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

December 03, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 28, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 27, 2025

Via The Motley Fool

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

November 27, 2025

Via The Motley Fool

Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗

November 27, 2025

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

August 17, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

August 13, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

August 09, 2025

From Pomerantz LLP

Via GlobeNewswire

Edgewise Therapeutics Inc (NASDAQ:EWTX) Q2 2025 Earnings: EPS Beat Sparks 5% Pre-Market Rally ↗

August 07, 2025

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

August 05, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

August 01, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 28, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 23, 2025

From Pomerantz LLP

Via GlobeNewswire

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

July 19, 2025

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 18, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 14, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 10, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 03, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

July 01, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

June 30, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Edgewise Therapeutics, Inc. - Common Stock publicly traded?

Yes, Edgewise Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Edgewise Therapeutics, Inc. - Common Stock trade on?

Edgewise Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Edgewise Therapeutics, Inc. - Common Stock?

The ticker symbol for Edgewise Therapeutics, Inc. - Common Stock is EWTX on the Nasdaq Stock Market

What is the current price of Edgewise Therapeutics, Inc. - Common Stock?

The current price of Edgewise Therapeutics, Inc. - Common Stock is 29.07

When was Edgewise Therapeutics, Inc. - Common Stock last traded?

The last trade of Edgewise Therapeutics, Inc. - Common Stock was at 01/29/26 02:36 PM ET

What is the market capitalization of Edgewise Therapeutics, Inc. - Common Stock?

The market capitalization of Edgewise Therapeutics, Inc. - Common Stock is 3.06B

How many shares of Edgewise Therapeutics, Inc. - Common Stock are outstanding?

Edgewise Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.